company background image
688046 logo

GemPharmatech SHSE:688046 Stock Report

Last Price

CN¥9.70

Market Cap

CN¥4.0b

7D

6.1%

1Y

-47.4%

Updated

16 Jul, 2024

Data

Company Financials +

GemPharmatech Co., Ltd.

SHSE:688046 Stock Report

Market Cap: CN¥4.0b

688046 Stock Overview

A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.

688046 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth5/6
Past Performance1/6
Financial Health6/6
Dividends2/6

GemPharmatech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GemPharmatech
Historical stock prices
Current Share PriceCN¥9.70
52 Week HighCN¥22.45
52 Week LowCN¥9.08
Beta0.20
11 Month Change-17.59%
3 Month Change-15.51%
1 Year Change-47.37%
33 Year Changen/a
5 Year Changen/a
Change since IPO-47.57%

Recent News & Updates

Some GemPharmatech Co., Ltd. (SHSE:688046) Shareholders Look For Exit As Shares Take 29% Pounding

Apr 16
Some GemPharmatech Co., Ltd. (SHSE:688046) Shareholders Look For Exit As Shares Take 29% Pounding

Recent updates

Some GemPharmatech Co., Ltd. (SHSE:688046) Shareholders Look For Exit As Shares Take 29% Pounding

Apr 16
Some GemPharmatech Co., Ltd. (SHSE:688046) Shareholders Look For Exit As Shares Take 29% Pounding

Shareholder Returns

688046CN Life SciencesCN Market
7D6.1%1.9%2.2%
1Y-47.4%-39.5%-18.6%

Return vs Industry: 688046 underperformed the CN Life Sciences industry which returned -39.5% over the past year.

Return vs Market: 688046 underperformed the CN Market which returned -18.6% over the past year.

Price Volatility

Is 688046's price volatile compared to industry and market?
688046 volatility
688046 Average Weekly Movement6.0%
Life Sciences Industry Average Movement6.4%
Market Average Movement6.5%
10% most volatile stocks in CN Market9.8%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 688046's share price has been volatile over the past 3 months.

Volatility Over Time: 688046's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20171,506Jing Zhaowww.gempharmatech.com

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services.

GemPharmatech Co., Ltd. Fundamentals Summary

How do GemPharmatech's earnings and revenue compare to its market cap?
688046 fundamental statistics
Market capCN¥3.99b
Earnings (TTM)CN¥157.34m
Revenue (TTM)CN¥638.97m

25.3x

P/E Ratio

6.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688046 income statement (TTM)
RevenueCN¥638.97m
Cost of RevenueCN¥213.21m
Gross ProfitCN¥425.76m
Other ExpensesCN¥268.42m
EarningsCN¥157.34m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 29, 2024

Earnings per share (EPS)0.38
Gross Margin66.63%
Net Profit Margin24.62%
Debt/Equity Ratio4.0%

How did 688046 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

42%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.